Daniel Clark
Stock Analyst at Leerink Partners
(2.53)
# 1,964
Out of 5,182 analysts
8
Total ratings
66.67%
Success rate
16.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Maintains: Outperform | $26 → $30 | $22.15 | +35.44% | 3 | Feb 24, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $568.30 | +5.58% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $116.65 | +32.88% | 2 | Jul 17, 2025 |
Elanco Animal Health
Feb 24, 2026
Maintains: Outperform
Price Target: $26 → $30
Current: $22.15
Upside: +35.44%
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $568.30
Upside: +5.58%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $116.65
Upside: +32.88%